Comparison Study of Sorafenib and 5-fluorouracil/Mitomycin for Metastatic Hepatocellular Carcinoma
Status:
Terminated
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The aim of this study is to compare the efficacy of sorafenib to 5-fluorouracil/mitomycin in
HCC patients with pulmonary metastasis whose intrahepatic tumors has been controlled with
locoregional therapies.